(Total Views: 500)
Posted On: 05/11/2022 11:23:16 PM
Post# of 157515
Gotcha, but didn’t Kelly touch on this last CC or did he deflect ?
I thought he made it seem like they weren’t going to continue to look at the mTNBC data any further for BTD?
I also thought they stop giving Leronlimab to people once the trial was over.
Maybe the present the data show it’s better and then apply for BTD.
I thought he made it seem like they weren’t going to continue to look at the mTNBC data any further for BTD?
I also thought they stop giving Leronlimab to people once the trial was over.
Maybe the present the data show it’s better and then apply for BTD.
(1)
(0)
Daniel Rizzo
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
